Andrew Whitehouse
Overview
Explore the profile of Andrew Whitehouse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1003
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Trembath D, Varcin K, Waddington H, Sulek R, Bent C, Ashburner J, et al.
Autism
. 2022 Sep;
27(2):275-295.
PMID: 36081343
The delivery of evidence-based interventions is an important part of the clinical pathway for many autistic children and their families. However, parents, practitioners, and policymakers face challenges making evidence informed...
22.
Neumann A, Nolte I, Pappa I, Ahluwalia T, Pettersson E, Rodriguez A, et al.
PLoS One
. 2022 Aug;
17(8):e0273116.
PMID: 35994476
Substantial genetic correlations have been reported across psychiatric disorders and numerous cross-disorder genetic variants have been detected. To identify the genetic variants underlying general psychopathology in childhood, we performed a...
23.
Leonard H, Whitehouse A, Jacoby P, Benke T, Demarest S, Saldaris J, et al.
Res Dev Disabil
. 2022 Aug;
129:104322.
PMID: 35939908
Objective: To compare quality of life (QOL) across diagnoses associated with intellectual disability, construct QOL profiles and evaluate membership by diagnostic group, function and comorbidities. Method: Primary caregivers of 526...
24.
Calder S, Brennan-Jones C, Robinson M, Whitehouse A, Hill E
J Paediatr Child Health
. 2022 Aug;
58(11):2044-2050.
PMID: 35922883
Aim: This study sought to determine the prevalence of Developmental Language Disorder (DLD) in Australian school-aged children and associated potential risk factors for DLD at 10 years. Methods: This study...
25.
Jacoby P, Williams K, Reddihough D, Leonard H, Whitehouse A, Downs J
Dev Med Child Neurol
. 2022 Mar;
64(9):1145-1155.
PMID: 35322406
Aim: To identify factors associated with quality of life (QoL) in children with intellectual disability. We aimed to identify patterns of association not observable in previous hypothesis-driven regression modelling using...
26.
Shields N, Epstein A, Jacoby P, Kim R, Leonard H, Reddihough D, et al.
Disabil Rehabil
. 2022 Feb;
44(4):600-607.
PMID: 35180033
Purpose: To investigate modifiable child and caregiver factors influencing community participation among children with Down syndrome. Methods: Cross-sectional data from a study investigating quality of life of children with intellectual...
27.
Stuart N, Whitehouse A, Palermo R, Bothe E, Badcock N
J Autism Dev Disord
. 2022 Feb;
53(5):1884-1905.
PMID: 35119604
Reduced eye contact early in life may play a role in the developmental pathways that culminate in a diagnosis of autism spectrum disorder. However, there are contradictory theories regarding the...
28.
Jacoby P, Whitehouse A, Leonard H, Saldaris J, Demarest S, Benke T, et al.
J Dev Behav Pediatr
. 2022 Jan;
43(6):e414-e418.
PMID: 35075044
Objective: The aim of this study was to devise an evidence-based missing data rule for the Quality of Life Inventory-Disability (QI-Disability) questionnaire specifying how many missing items are permissible for...
29.
Masi A, Azim S, Lam-Cassettari C, Dadds M, Mendoza Diaz A, Henry G, et al.
Int J Environ Res Public Health
. 2021 Dec;
18(23).
PMID: 34886563
Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally...
30.
An evidence-based framework for determining the optimal amount of intervention for autistic children
Trembath D, Waddington H, Sulek R, Varcin K, Bent C, Ashburner J, et al.
Lancet Child Adolesc Health
. 2021 Oct;
5(12):896-904.
PMID: 34672993
The provision of timely, effective, and socially valid non-pharmacological intervention is at the core of efforts to support the development of young autistic children. These efforts are intended to support...